Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5161 Target Snapshot

NPC1-like intracellular cholesterol transporter 1 · SINGLE PROTEIN · Rattus norvegicus

38Compounds
4Assays
1Approved Drugs
41.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q6T3U3. Use UniProt Q6T3U3 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q6T3U3 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats NPC1-like intracellular cholesterol transporter 1 as ChEMBL target CHEMBL5161, mapped to UniProt Q6T3U3. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
NPC1-like intracellular cholesterol transporter 1
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL5161
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q6T3U3
NPC1-like intracellular cholesterol transporter 1
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether NPC1-like intracellular cholesterol transporter 1 is the right protein anchor across sources, using UniProt Q6T3U3 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelNPC1-like intracellular cholesterol transporter 1
UniProt AccessionQ6T3U3
Component TypeProtein
Sequence Length1331 aa

NPC1-like intracellular cholesterol transporter 1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as NPC1-like intracellular cholesterol transporter 1, mapped to UniProt Q6T3U3. Sequence length is 1331 aa.

Mapped IDQ6T3U3
Review nameNPC1-like intracellular cholesterol transporter 1
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC508.0
KI33.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL578400 8.4 IC50 4.0 Preclinical
CHEMBL504066 7.8 IC50 16.0 Preclinical
CHEMBL578401 6.9 IC50 127.0 Preclinical
CHEMBL321017 6.75 Ki 180.0 Preclinical
CHEMBL1138 6.7 Ki 200.0 Approved
CHEMBL321017 6.24 IC50 580.0 Preclinical
CHEMBL271655 5.85 Ki 1400.0 Preclinical
CHEMBL271634 5.64 Ki 2300.0 Preclinical
CHEMBL258358 5.44 Ki 3600.0 Preclinical
CHEMBL257848 5.32 Ki 4800.0 Preclinical
Distribution

pChEMBL Value Distribution

6
5.0
2
5.5
1
6.0
4
6.5
0
7.0
1
7.5
2
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

EZETIMIBE
CHEMBL1138
Approved 2002
Assay Landscape

Assay Landscape

4
Total Assays
31
Tested Compounds
1
Assay Types
Binding — 4 assays, 31 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 3 29 5.4
cell-based format 1 2 7.6

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine